Medications

Epstein-Barr virus associated tumors and drug repurposing

A new study published in OMICS: A Journal of Integrative Biology identified differentially expressed host and viral microRNAs (miRNAs) in six Epstein-Barr virus (EBV) associated tumors. The study reports several drug candidates ...

Oncology & Cancer

Novel index IDs prognosis in adults with Burkitt lymphoma

(HealthDay)—The Burkitt lymphoma (BL) International Prognostic Index (BL-IPI) provides robust discrimination of survival and can be used for prognostication, according to a study published online Jan. 27 in the Journal ...

Oncology & Cancer

Apoptosis inhibitor enables some lymphomas to resist therapy

Lymphomas are a diverse group of cancers of the immune system, which is the body's primary defense against autoimmune disease, infections, and malignancy. Now, researchers at the University of Tsukuba have clarified risk ...

Oncology & Cancer

Childhood cancer rates increase with no change in sight

The overall incidence rate of childhood cancer in Australia increased by 1.2% per year between 2005 and 2015, and is expected to rise a further 7% over the next 20 years, according to the authors of research published in ...

page 1 from 2